France reports 22,882 new Covid cases; tally at 2,109,170
- November 21, 2020
- Updated: 07:38 am
Paris, Nov 21 : France has reported 22,882 fresh Covid-19 cases, pushing the tally to 2,109,170, while the number of hospitalizations continued to decline in the country, data released by health authorities said.
In a 24-hour span, an additional 1,138 patients have succumbed to Covid-19, including 757 deaths registered in nursing homes which are counted twice a week, on Tuesdays and Fridays, Xinhua reported.
The pressure on health services continued to ease as coronavirus-related hospitalizations dropped for the fourth day in a row.
A total of 31,906 Covid-19 patients remained in hospital, a single-day decline of 439, with 4,582 patients in intensive care, down by 71.
An improvement in pandemic indicators have given rise to calls for easing restrictions on travel across the country to join families for Christmas holiday.
People line up in front of an outlet of a housekeeping service provider in Paris, France, November 18, 2020.
In addition, shop owners who have to suspend their businesses during the 4-week confinement, are asking to reopen for the November 27-29 Black Friday weekend and year-end shopping season.
Introduced since October 30, the confinement rules remain effective until early December. The government could impose more restrictions beyond the initial deadline if curbs fail to brake the virus resurgence, or decide to loosen rules if the epidemic situation allows.
President Emmanuel Macron will make a TV appearance on Tuesday evening to announce "an adapted confinement" or "a gradual exit" from the lockdown, BFM TV news channel reported, citing government officials.
As the world is struggling to contain the pandemic, countries including France, China, Russia, the United Kingdom and the United States are racing to find a vaccine.
According to the website of the World Health Organization, as of November 12, there were 212 Covid-19 candidate vaccines being developed worldwide, and 48 of them were in clinical trials.
/IANS